Animal models recapitulating the multifactorial origin of tourette syndrome

International Review of Neurobiology

Volumn 112, Issue , 2013, Pages 211-237

  Macrì, Simone ^a   Onori, Martina Proietti ^a   Roessner, Veit ^b   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Autoimmunity; Environment; Genetics; PANDAS; Rodents; Tic disorders

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; HALOPERIDOL; HISTIDINE DECARBOXYLASE; PAROXETINE; SEROTONIN; STREPTOCOCCUS VACCINE;

ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; AUTISM; BASAL GANGLION; BEHAVIOR DISORDER; BRAIN FUNCTION; CNTNAP2 GENE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EXPERIMENTAL ANIMAL; GABAERGIC SYSTEM; GENE; GENETIC PREDISPOSITION; GILLES DE LA TOURETTE SYNDROME; GROUP A STREPTOCOCCAL INFECTION; HDC GENE; HEREDITY; HUMAN; IMMUNIZATION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INTERNEURON; LANGUAGE DISABILITY; LOCOMOTION; MENTAL STRESS; MOTOR DYSFUNCTION; NEUROBIOLOGY; NEUROIMMUNOLOGY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RODENT; STEREOTYPY; STREPTOCOCCUS GROUP A; SYMPTOM; TIC; TRANSGENIC ANIMAL;

AUTOIMMUNITY; ENVIRONMENT; GENETICS; PANDAS; RODENTS; TIC DISORDERS;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENVIRONMENT; HUMANS; NEUROTRANSMITTER AGENTS; TOURETTE SYNDROME;

EID: 84888405224     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-411546-0.00008-1     Document Type: Chapter

References (154)

1. Abelson J.F., Kwan K.Y., O'Roak B.J., Baek D.Y., Stillman A.A., Morgan T.M., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310(5746):317-320.
2. Abrahams B.S., Tentler D., Perederiy J.V., Oldham M.C., Coppola G., Geschwind D.H. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(45):17849-17854.
3. Adamcio B., Havemann-Reinecke U., Ehrenreich H. Chronic psychosocial stress in the absence of social support induces pathological pre-pulse inhibition in mice. Behavioural Brain Research 2009, 204(1):246-249.
4. Ader R. Early experiences accelerate maturation of the 24-hour adrenocortical rhythm. Science 1969, 163(3872):1225-1226.
5. Albin R.L., Koeppe R.A., Bohnen N.I., Nichols T.E., Meyer P., Wernette K., et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003, 61(3):310-315.
6. Alzghoul L., Bortolato M., Delis F., Thanos P.K., Darling R.D., Godar S.C., et al. Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice. Neuropharmacology 2012, 63(7):1208-1217.
7. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR〉 2000, American Psychiatric Publishing. 4th ed.
8. Arnsten A.F. Modulation of prefrontal cortical-striatal circuits: Relevance to therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity disorder. Advances in Neurology 2001, 85:333-341.
9. Arnsten A.F.T., Pliszka S.R. Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders. Pharmacology, Biochemistry, and Behavior 2011, 99(2):211-216.
10. Bakker J.M., Van Bel F., Heijnen C.J. Neonatal glucocorticoids and the developing brain: Short-term treatment with life-long consequences?. Trends in Neurosciences 2001, 24(11):649-653.
11. Bartlang M.S., Neumann I.D., Slattery D.A., Uschold-Schmidt N., Kraus D., Helfrich-Förster C., et al. Time matters: Pathological effects of repeated psychosocial stress during the active, but not inactive, phase of male mice. The Journal of Endocrinology 2012, 215(3):425-437.
12. Bartolomucci A., Palanza P., Sacerdote P., Panerai A.E., Sgoifo A., Dantzer R., et al. Social factors and individual vulnerability to chronic stress exposure. Neuroscience and Biobehavioral Reviews 2005, 29(1):67-81.
13. Belloso J.M., Bache I., Guitart M., Caballin M.R., Halgren C., Kirchhoff M., et al. Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. European Journal of Human Genetics 2007, 15(6):711-713.
14. Berardelli A., Currà A., Fabbrini G., Gilio F., Manfredi M. Pathophysiology of tics and Tourette syndrome. Journal of Neurology 2003, 250(7):781-787.
15. Bilbo S.D., Biedenkapp J.C., Der-Avakian A., Watkins L.R., Rudy J.W., Maier S.F. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. Journal of Neuroscience 2005, 25(35):8000-8009.
16. Bilbo S.D., Schwarz J.M. Early-life programming of later-life brain and behavior: A critical role for the immune system. Frontiers in Behavioral Neuroscience 2009, 3:14.
17. Blanchard R.J., McKittrick C.R., Blanchard D.C. Animal models of social stress: Effects on behavior and brain neurochemical systems. Physiology and Behavior 2001, 73(3):261-271.
18. Blanchard D.C., Spencer R.L., Weiss S.M., Blanchard R.J., McEwen B., Sakai R.R. Visible burrow system as a model of chronic social stress: Behavioral and neuroendocrine correlates. Psychoneuroendocrinology 1995, 20(2):117-134.
19. Bliss J. Sensory experiences of Gilles de la Tourette syndrome. Archives of General Psychiatry 1980, 37(12):1343-1347.
20. Bortolato M., Chen K., Godar S.C., Chen G., Wu W., Rebrin I., et al. Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology 2011, 36(13):2674-2688.
21. Bortolato M., Chen K., Shih J.C. Monoamine oxidase inactivation: From pathophysiology to therapeutics. Advanced Drug Delivery Reviews 2008, 60(13-14):1527-1533.
22. Brimberg L., Benhar I., Mascaro-Blanco A., Alvarez K., Lotan D., Winter C., et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: A novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012, 37(9):2076-2087.
23. Bronfeld M., Israelashvili M., Bar-Gad I. Pharmacological animal models of Tourette syndrome. Neuroscience and Biobehavioral Reviews 2012, 37(6):1101-1119.
24. Buse J., Schoenefeld K., Münchau A., Roessner V. Neuromodulation in Tourette syndrome: Dopamine and beyond. Neuroscience and Biobehavioral Reviews 2013, 37(6):1069-1084.
25. Buwalda B., Kole M.H.P., Veenema A.H., Huininga M., De Boer S.F., Korte S.M., et al. Long-term effects of social stress on brain and behavior: A focus on hippocampal functioning. Neuroscience and Biobehavioral Reviews 2005, 29(1):83-97.
26. Campbell K.M., McGrath M.J., Burton F.H. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion. Brain Research 1999, 833(2):216-224.
27. Canal C.E., Morgan D. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: A comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Testing and Analysis 2012, 4(7-8):556-576.
28. Cardona F., Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. The Journal of Pediatrics 2001, 138(1):71-75.
29. Chappell P., Riddle M., Anderson G., Scahill L., Hardin M., Walker D., et al. Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture. Biological Psychiatry 1994, 36(1):35-43.
30. Chen S.-K., Tvrdik P., Peden E., Cho S., Wu S., Spangrude G., et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010, 141(5):775-785.
31. Cheon K.-A., Ryu Y.-H., Namkoong K., Kim C.-H., Kim J.-J., Lee J.D. Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder. Psychiatry Research 2004, 130(1):85-95.
32. Cohen S.C., Leckman J.F., Bloch M.H. Clinical assessment of Tourette syndrome and tic disorders. Neuroscience and Biobehavioral Reviews 2013, 37(6):997-1007.
33. Comings D.E. Blood serotonin and tryptophan in Tourette syndrome. American Journal of Medical Genetics 1990, 36(4):418-430.
34. Comings D.E., Comings B.G., Muhleman D., Dietz G., Shahbahrami B., Tast D., et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. The Journal of the American Medical Association 1991, 266(13):1793-1800.
35. Conelea C.A., Woods D.W. The influence of contextual factors on tic expression in Tourette's syndrome: A review. Journal of Psychosomatic Research 2008, 65(5):487-496.
36. Conelea C.A., Woods D.W., Brandt B.C. The impact of a stress induction task on tic frequencies in youth with Tourette Syndrome. Behaviour Research and Therapy 2011, 49(8):492-497.
37. Corbett B.A., Mendoza S.P., Baym C.L., Bunge S.A., Levine S. Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome. Psychoneuroendocrinology 2008, 33(6):810-820.
38. Dale R.C., Candler P.M., Church A.J., Wait R., Pocock J.M., Giovannoni G. Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease. Journal of Neuroimmunology 2006, 172(1-2):187-197.
39. Dantzer R. Behavioral, physiological and functional aspects of stereotyped behavior: A review and a re-interpretation. Journal of Animal Science 1986, 62(6):1776-1786.
40. Deng H., Gao K., Jankovic J. The genetics of Tourette syndrome. Nature Reviews Neurology 2012, 8(4):203-213.
41. Díaz-Anzaldúa A., Joober R., Rivière J.-B., Dion Y., Lespérance P., Richer F., et al. Tourette syndrome and dopaminergic genes: A family-based association study in the French Canadian founder population. Molecular Psychiatry 2004, 9(3):272-277.
42. Dursun S.M., Handley S.L. Serotonin, eating disorders, and HIV infection. The British Journal of Psychiatry 1992, 160:866-867.
43. Ercan-Sencicek A.G., Stillman A.A., Ghosh A.K., Bilguvar K., O'Roak B.J., Mason C.E., et al. L-histidine decarboxylase and Tourette's syndrome. The New England Journal of Medicine 2010, 362(20):1901-1908.
44. Felling R.J., Singer H.S. Neurobiology of tourette syndrome: Current status and need for further investigation. Journal of Neuroscience 2011, 31(35):12387-12395.
45. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity. Physiological Reviews 1983, 63(3):844-914.
46. Fuchs E. Social stress in tree shrews as an animal model of depression: An example of a behavioral model of a CNS disorder. CNS Spectrums 2005, 10(3):182-190.
47. Ganos C., Roessner V., Münchau A. The functional anatomy of Gilles de la Tourette syndrome. Neuroscience and Biobehavioral Reviews 2013, 37(6):1050-1062.
48. Garner J.P., Mason G.J. Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents. Behavioural Brain Research 2002, 136(1):83-92.
49. Garner J.P., Meehan C.L., Mench J.A. Stereotypies in caged parrots, schizophrenia and autism: Evidence for a common mechanism. Behavioural Brain Research 2003, 145(1-2):125-134.
50. Greer J.M., Capecchi M.R. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002, 33(1):23-34.
51. Gross A.N., Richter S.H., Engel A.K.J., Würbel H. Cage-induced stereotypies, perseveration and the effects of environmental enrichment in laboratory mice. Behavioural Brain Research 2012, 234(1):61-68.
52. Haas H.L., Sergeeva O.A., Selbach O. Histamine in the nervous system. Physiological Reviews 2008, 88(3):1183-1241.
53. Hallett J.J., Harling-Berg C.J., Knopf P.M., Stopa E.G., Kiessling L.S. Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction. Journal of Neuroimmunology 2000, 111(1-2):195-202.
54. Heinrichs M., Gaab J. Neuroendocrine mechanisms of stress and social interaction: Implications for mental disorders. Current Opinion in Psychiatry 2007, 20(2):158-162.
55. Hoekstra P.J., Dietrich A., Edwards M.J., Elamin I., Martino D. Environmental factors in Tourette syndrome. Neuroscience and Biobehavioral Reviews 2013, 37(6):1040-1049.
56. Hoffman K.L., Hornig M., Yaddanapudi K., Jabado O., Lipkin W.I. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. Journal of Neuroscience 2004, 24(7):1780-1791.
57. Hohmann C.F., Hodges A., Beard N., Aneni J. Effects of brief stress exposure during early postnatal development in balb/CByJ mice: I. Behavioral characterization. Developmental Psychobiology 2013, 55(3):283-293.
58. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neuroscience and Biobehavioral Reviews 2008, 32(7):1293-1314.
59. Hornig M., Lipkin W.I. Immune-mediated animal models of Tourette syndrome. Neuroscience and Biobehavioral Reviews 2013, 37(6):1120-1138.
60. Huber L., Ferdin M., Holzmann J., Stubbusch J., Rohrer H. HoxB8 in noradrenergic specification and differentiation of the autonomic nervous system. Developmental Biology 2012, 363(1):219-233.
61. Jankovic J., Kurlan R. Tourette syndrome: Evolving concepts. Movement Disorders 2011, 26(6):1149-1156.
62. Jung J., Jackson S.R., Parkinson A., Jackson G.M. Cognitive control over motor output in Tourette syndrome. Neuroscience and Biobehavioral Reviews 2012, 37(6):1016-1025.
63. Kajiwara Y., Buxbaum J.D., Grice D.E. SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. Biological Psychiatry 2009, 66(10):918-925.
64. Kang H., Zhang Y.-F., Jiao F.-Y., Guo X.-Y., Gao X.-M. Efficacy of clonidine transdermal patch for treatment of Tourette's syndrome in children. Chinese Journal of Contemporary Pediatrics 2009, 11(7):537-539.
65. Karagiannidis I., Dehning S., Sandor P., Tarnok Z., Rizzo R., Wolanczyk T., et al. Support of the histaminergic hypothesis in Tourette Syndrome: Association of the histamine decarboxylase gene in a large sample of families. Journal of Medical Genetics 2013.
66. Katayama K., Yamada K., Ornthanalai V.G., Inoue T., Ota M., Murphy N.P., et al. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Molecular Psychiatry 2010, 15(2):177-184.
67. Kawikova I., Grady B.P.X., Tobiasova Z., Zhang Y., Vojdani A., Katsovich L., et al. Children with Tourette's syndrome may suffer immunoglobulin A dysgammaglobulinemia: Preliminary report. Biological Psychiatry 2010, 67(7):679-683.
68. Kerr D., Krishnan C., Pucak M.L., Carmen J. The immune system and neuropsychiatric diseases. International Review of Psychiatry 2005, 17(6):443-449.
69. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics 1993, 92(1):39-43.
70. Kiessling L.S., Marcotte A.C., Culpepper L. Antineuronal antibodies: Tics and obsessive-compulsive symptoms. Journal of Developmental and Behavioral Pediatrics 1994, 15(6):421-425.
71. Kleinhaus K., Steinfeld S., Balaban J., Goodman L., Craft T.S., Malaspina D., et al. Effects of excessive glucocorticoid receptor stimulation during early gestation on psychomotor and social behavior in the rat. Developmental Psychobiology 2010, 52(2):121-132.
72. Korff S., Harvey B.H. Animal models of obsessive-compulsive disorder: Rationale to understanding psychobiology and pharmacology. The Psychiatric Clinics of North America 2006, 29(2):371-390.
73. Kubota Y., Ito C., Sakurai E., Sakurai E., Watanabe T., Ohtsu H. Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice. Journal of Neurochemistry 2002, 83(4):837-845.
74. Kudryavtseva N.N. A sensory contact model for the study of aggressive and submissive behavior in male mice. Aggressive Behavior 1991, 17(5):285-291.
75. Kurlan R., McDermott M.P., Deeley C., Como P.G., Brower C., Eapen S., et al. Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001, 57(8):1383-1388.
76. Laviola G., Adriani W., Rea M., Aloe L., Alleva E. Social withdrawal, neophobia, and stereotyped behavior in developing rats exposed to neonatal asphyxia. Psychopharmacology 2004, 175(2):196-205.
77. Lawson-Yuen A., Saldivar J.-S., Sommer S., Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. European Journal of Human Genetics 2008, 16(5):614-618.
78. Leckman James F. Tic disorders. British Medical Journal 2012, 344:d7659.
79. Leckman James F., Bloch M.H., Smith M.E., Larabi D., Hampson M. Neurobiological substrates of Tourette's disorder. Journal of Child and Adolescent Psychopharmacology 2010, 20(4):237-247.
80. Leckman J.F., Dolnansky E.S., Hardin M.T., Clubb M., Walkup J.T., Stevenson J., et al. Perinatal factors in the expression of Tourette's syndrome: An exploratory study. Journal of the American Academy of Child and Adolescent Psychiatry 1990, 29(2):220-226.
81. Leckman J.F., Hardin M.T., Riddle M.A., Stevenson J., Ort S.I., Cohen D.J. Clonidine treatment of Gilles de la Tourette's syndrome. Archives of General Psychiatry 1991, 48(4):324-328.
82. Leckman J.F., Peterson B.S. The pathogenesis of Tourette's syndrome: Epigenetic factors active in early CNS development. Biological Psychiatry 1993, 34(7):425-427.
83. Leckman J.F., Price R.A., Walkup J.T., Ort S., Pauls D.L., Cohen D.J. Nongenetic factors in Gilles de la Tourette's syndrome. Archives of General Psychiatry 1987, 44(1):100.
84. Lee C.-C., Chou I.-C., Tsai C.-H., Wang T.-R., Li T.-C., Tsai F.-J. Dopamine receptor D2 gene polymorphisms are associated in Taiwanese children with Tourette syndrome. Pediatric Neurology 2005, 33(4):272-276.
85. Lin H., Williams K.A., Katsovich L., Findley D.B., Grantz H., Lombroso P.J., et al. Streptococcal upper respiratory tract infections and psychosocial stress predict future tic and obsessive-compulsive symptom severity in children and adolescents with Tourette syndrome and obsessive-compulsive disorder. Biological Psychiatry 2010, 67(7):684-691.
86. Linhoff M.W., Laurén J., Cassidy R.M., Dobie F.A., Takahashi H., Nygaard H.B., et al. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 2009, 61(5):734-749.
87. Liu L., Li A., Matthews S.G. Maternal glucocorticoid treatment programs HPA regulation in adult offspring: Sex-specific effects. American Journal of Physiology 2001, 280(5):729-739.
88. Lombroso P.J., Scahill L. Tourette syndrome and obsessive-compulsive disorder. Brain and Development 2008, 30(4):231-237.
89. Maccari S., Morley-Fletcher S. Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations. Psychoneuroendocrinology 2007, 32(Suppl. 1):S10-S15.
90. Macrì S., Granstrem O., Shumilina M., Gomes Antunes, dos Santos F.J., Berry A., et al. Resilience and vulnerability are dose-dependently related to neonatal stressors in mice. Hormones and Behavior 2009, 56(4):391-398.
91. Macrí S., Mason G.J., Würbel H. Dissociation in the effects of neonatal maternal separations on maternal care and the offspring's HPA and fear responses in rats. The European Journal of Neuroscience 2004, 20(4):1017-1024.
92. Macrì S., Proietti Onori M., Laviola G. Theoretical and practical considerations behind the use of laboratory animals for the study of Tourette syndrome. Neuroscience and Biobehavioral Reviews 2013, 37(6):1085-1100.
93. Macrì S., Zoratto F., Laviola G. Early-stress regulates resilience, vulnerability and experimental validity in laboratory rodents through mother-offspring hormonal transfer. Neuroscience and Biobehavioral Reviews 2011, 35(7):1534-1543.
94. Marco E.M., Macrì S., Laviola G. Critical age windows for neurodevelopmental psychiatric disorders: Evidence from animal models. Neurotoxicity Research 2011, 19(2):286-307.
95. Martino D., Chiarotti F., Buttiglione M., Cardona F., Creti R., Nardocci N., et al. The relationship between group A streptococcal infections and Tourette syndrome: A study on a large service-based cohort. Developmental Medicine and Child Neurology 2011, 53(10):951-957.
96. Martino D., Giovannoni G. Antibasal ganglia antibodies and their relevance to movement disorders. Current Opinion in Neurology 2004, 17(4):425-432.
97. Maślińska D. The cytokine network and interleukin-15 (IL-15) in brain development. Folia Neuropathologica/Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences 2001, 39(2):43-47.
98. McKenzie G.M., Gordon R.J., Viik K. Some biochemical and behavioural correlates of a possible animal model of human hyperkinetic syndromes. Brain Research 1972, 47(2):439-456.
99. Meaney M.J., Diorio J., Francis D., Weaver S., Yau J., Chapman K., et al. Postnatal handling increases the expression of cAMP-inducible transcription factors in the rat hippocampus: The effects of thyroid hormones and serotonin. The Journal of neuroscience 2000, 20(10):3926-3935.
100. Mell L.K., Davis R.L., Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder. Pediatrics 2005, 116(1):56-60.
101. Morley-Fletcher S., Rea M., Maccari S., Laviola G. Environmental enrichment during adolescence reverses the effects of prenatal stress on play behaviour and HPA axis reactivity in rats. The European Journal of Neuroscience 2003, 18(12):3367-3374.
102. Morris C.M., Pardo-Villamizar C., Gause C.D., Singer H.S. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. Journal of the Neurological Sciences 2009, 276(1-2):45-48.
103. Nilsson C., Jennische E., Ho H.-P., Eriksson E., Bjorntorp P., Holmang A. Postnatal endotoxin exposure results in increased insulin sensitivity and altered activity of neuroendocrine axes in adult female rats. European Journal of Endocrinology/European Federation of Endocrine Societies 2002, 146(2):251-260.
104. Nordstrom E.J., Burton F.H. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Molecular Psychiatry 2002, 7(6):617-625. 524.
105. Nyuyki K.D., Beiderbeck D.I., Lukas M., Neumann I.D., Reber S.O. Chronic subordinate colony housing (CSC) as a model of chronic psychosocial stress in male rats. PLoS one 2012, 7(12):e52371.
106. O'Rourke J.A., Scharf J.M., Yu D., Pauls D.L. The genetics of Tourette syndrome: A review. Journal of Psychosomatic Research 2009, 67(6):533-545.
107. Paschou P. The genetic basis of Gilles de la Tourette Syndrome. Neuroscience and Biobehavioral Reviews 2013, 37(6):1026-1039.
108. Patel C., Cooper-Charles L., McMullan D.J., Walker J.M., Davison V., Morton J. Translocation breakpoint at 7q31 associated with tics: Further evidence for IMMP2L as a candidate gene for Tourette syndrome. European Journal of Human Genetics 2011, 19(6):634-639.
109. Patel S., Slater P. Analysis of the brain regions involved in myoclonus produced by intracerebral picrotoxin. Neuroscience 1987, 20(2):687-693.
110. Pauls D.L. Issues in genetic linkage studies of Tourette syndrome. Phenotypic spectrum and genetic model parameters. Advances in Neurology 1992, 58:151-157.
111. Pellow S., Chopin P., File S.E., Briley M. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 1985, 14(3):149-167.
112. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nature Reviews. Neuroscience 2003, 4(2):103-112.
113. Petek E., Windpassinger C., Vincent J.B., Cheung J., Boright A.P., Scherer S.W., et al. Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. American Journal of Human Genetics 2001, 68(4):848-858.
114. Poliak S., Gollan L., Martinez R., Custer A., Einheber S., Salzer J.L., et al. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron 1999, 24(4):1037-1047.
115. Ponzio N.M., Servatius R., Beck K., Marzouk A., Kreider T. Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring. Annals of the New York Academy of Sciences 2007, 1107:118-128.
116. Price R.A., Kidd K.K., Cohen D.J., Pauls D.L., Leckman J.F. A twin study of Tourette syndrome. Archives of General Psychiatry 1985, 42(8):815-820.
117. Proenca C.C., Gao K.P., Shmelkov S.V., Rafii S., Lee F.S. Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends in Neurosciences 2011, 34(3):143-153.
118. Randolph C., Hyde T.M., Gold J.M., Goldberg T.E., Weinberger D.R. Tourette's syndrome in monozygotic twins. Relationship of tic severity to neuropsychological function. Archives of Neurology 1993, 50(7):725-728.
119. Reber S.O., Birkeneder L., Veenema A.H., Obermeier F., Falk W., Straub R.H., et al. Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: Implications and mechanisms. Endocrinology 2007, 148(2):670-682.
120. Robertson M.M. The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: The epidemiological and prevalence studies. Journal of Psychosomatic Research 2008, 65(5):461-472.
121. Robertson H.R., Feng G. Annual research review: Transgenic mouse models of childhood-onset psychiatric disorders. Journal of Child Psychology and Psychiatry, and Allied Disciplines 2011, 52(4):442-475.
122. Scahill L., Riddle M.A., King R.A., Hardin M.T., Rasmusson A., Makuch R.W., et al. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: A double-blind placebo-controlled study. Journal of Child and Adolescent Psychopharmacology 1997, 7(2):75-85.
123. Schmidt D., Reber S.O., Botteron C., Barth T., Peterlik D., Uschold N., et al. Chronic psychosocial stress promotes systemic immune activation and the development of inflammatory Th cell responses. Brain, Behavior, and Immunity 2010, 24(7):1097-1104.
124. Schmidt M.V., Sterlemann V., Ganea K., Liebl C., Alam S., Harbich D., et al. Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence. Psychoneuroendocrinology 2007, 32(5):417-429.
125. Schrag A., Gilbert R., Giovannoni G., Robertson M.M., Metcalfe C., Ben-Shlomo Y. Streptococcal infection, Tourette syndrome, and OCD: Is there a connection?. Neurology 2009, 73(16):1256-1263.
126. Seuchter S.A., Hebebrand J., Klug B., Knapp M., Lehmkuhl G., Poustka F., et al. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome. Genetic Epidemiology 2000, 18(1):33-47.
127. Singer H.S., Butler I.J., Tune L.E., Seifert W.E., Coyle J.T. Dopaminergic dsyfunction in Tourette syndrome. Annals of Neurology 1982, 12(4):361-366.
128. Singer Harvey S., Gause C., Morris C., Lopez P. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 2008, 121(6):1198-1205.
129. Singer H.S., Giuliano J.D., Hansen B.H., Hallett J.J., Laurino J.P., Benson M., et al. Antibodies against human putamen in children with Tourette syndrome. Neurology 1998, 50(6):1618-1624.
130. Singer Harvey S., Hong J.J., Yoon D.Y., Williams P.N. Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 2005, 65(11):1701-1707.
131. Singer Harvey S., Minzer K. Neurobiology of Tourette's syndrome: Concepts of neuroanatomic localization and neurochemical abnormalities. Brain and Development 2003, 25(Suppl. 1):S70-S84.
132. Smith S.E.P., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. The Journal of Neuroscience 2007, 27(40):10695-10702.
133. State M.W. The genetics of Tourette disorder. Current Opinion in Genetics and Development 2011, 21(3):302-309.
134. Sterlemann V., Ganea K., Liebl C., Harbich D., Alam S., Holsboer F., et al. Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: Implications for stress-related disorders. Hormones and Behavior 2008, 53(2):386-394.
135. Stillman A.A., Krsnik Z., Sun J., Rasin M.-R., State M.W., Sestan N., et al. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. The Journal of Comparative Neurology 2009, 513(1):21-37.
136. Swain J.E., Scahill L., Lombroso P.J., King R.A., Leckman J.F. Tourette syndrome and tic disorders: A decade of progress. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46(8):947-968.
137. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. The American Journal of Psychiatry 1998, 155(2):264-271.
138. Taylor J.R., Morshed S.A., Parveen S., Mercadante M.T., Scahill L., Peterson B.S., et al. An animal model of Tourette's syndrome. The American Journal of Psychiatry 2002, 159(4):657-660.
139. Tse S.Y., Wei E.T. Inhibition of the shake response in rats by adenosine and 2-chloroadenosine. Psychopharmacology 1986, 90(3):322-326.
140. Van Der Staay F.J., Arndt S.S., Nordquist R.E. Evaluation of animal models of neurobehavioral disorders. Behavioral and Brain Functions 2009, 5(1):11.
141. Verkerk A., Mathews C., Joosse M., Eussen B., Heutink P., Oostra B. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 2003, 82(1):1-9.
142. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Progress in Neurobiology 2001, 65(5):427-451.
143. Weisman H., Qureshi I.A., Leckman J.F., Scahill L., Bloch M.H. Systematic review: Pharmacological treatment of tic disorders-Efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neuroscience and Biobehavioral Reviews 2013, 37(6):1162-1171.
144. Wendlandt J.T., Grus F.H., Hansen B.H., Singer H.S. Striatal antibodies in children with Tourette's syndrome: Multivariate discriminant analysis of IgG repertoires. Journal of Neuroimmunology 2001, 119(1):106-113.
145. Willis C.L. Imaging in vivo astrocyte/endothelial cell interactions at the blood-brain barrier. Methods in Molecular Biology 2012, 814:515-529.
146. Willner P. Chronic mild stress (CMS) revisited: Consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52(2):90-110.
147. Wolf S.S., Jones D.W., Knable M.B., Gorey J.G., Lee K.S., Hyde T.M., et al. Tourette syndrome: Prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 1996, 273(5279):1225-1227.
148. Wood B.L., Klebba K., Gbadebo O., Lichter D., Kurlan R., Miller B. Pilot study of effect of emotional stimuli on tic severity in children with Tourette's syndrome. Movement Disorders 2003, 18(11):1392-1395.
149. Yaddanapudi K., Hornig M., Serge R., De Miranda J., Baghban A., Villar G., et al. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Molecular Psychiatry 2010, 15(7):712-726.
150. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Research 1994, 643(1-2):40-49.
151. Zalcman S., Murray L., Dyck D.G., Greenberg A.H., Nance D.M. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Research 1998, 811(1-2):111-121.
152. Zalcman S.S., Patel A., Mohla R., Zhu Y., Siegel A. Soluble cytokine receptors (sIL-2Rα, sIL-2Rβ) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain. PLoS one 2012, 7(4):e36316.
153. Zhang-James Y., Middleton F.A., Faraone S.V. Genetic architecture of Wistar Kyoto rats (WKY) and Spontaneous hypertensive Rats (SHR) substrains from difference sources. Physiological Genomics 2013, 45:528-538.
154. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(4):1982-1987.